Summary Company Announcement Date: January 24, 2025 FDA Publish Date: January 24, 2025 Product Type: Food & Beverages Allergens Reason for Announcement: Recall Reason Description Potential or Undeclared Allergen – soy Company Name: TS FOOD PACKAGING Brand Name: Brand Name(s) Wabash Valley Farms, Rural King Product Description: Product Description Bacon flavor popcorn seasoning Company Announcement…
Copaxone, Glatopa (glatiramer acetate): Drug Safety Communication – FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis
[Posted 01/22/2025] AUDIENCE: Patient, Caregiver, Health Care Professional, Pharmacy, Neurology ISSUE: The FDA is warning about the risk of a rare but serious allergic reaction with the medicine glatiramer acetate (Copaxone, Glatopa), which is used to treat patients with multiple sclerosis (MS). This serious allergic reaction, called anaphylaxis, can occur at any time while on…
Apna Wholesale Issues Alert on Undeclared Sulfites in “Paras Premium Golden Raisins
Summary Company Announcement Date: January 07, 2025 FDA Publish Date: January 22, 2025 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Undeclared Sulfites Company Name: Apna Wholesale Inc Brand Name: Brand Name(s) Product Description: Product Description Premium Golden Raisins Company Announcement Apna Wholesale Inc of Hicksville, NY, is recalling its 7oz and…
D. Coluccio & Sons, Issues Allergy Alert on Undeclared Almonds in “Colussi Cantuccini Chocolate Drops” Cookies
Summary Company Announcement Date: January 21, 2025 FDA Publish Date: January 21, 2025 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Undeclared almond Company Name: D. Coluccio & Sons Brand Name: Brand Name(s) Product Description: Product Description “Colussi Cantuccini Chocolate Drops” chocolate chip cookies Company Announcement D. COLUCCIO & SONS, in is…
Columbia County Woman Sentenced to Federal Prison for Role in Wire Fraud Conspiracy and Illegally Dispensing Animal Drugs
Department of JusticeU.S. Attorney’s OfficeDistrict of Oregon FOR IMMEDIATE RELEASEJanuary 17, 2025 PORTLAND, Ore.—A Columbia County, Oregon woman was sentenced to federal prison Thursday for her role in a conspiracy to defraud customers seeking to adopt pets and illegally dispensing prescription animal drugs without a lawful order of a veterinarian. Samantha Miller, 55, was sentenced…
Wismettac Asian Foods Issues Allergy Alert on Undeclared Milk in Curvee Puffs Corn Puff Snack Curry Flavor
Summary Company Announcement Date: January 17, 2025 FDA Publish Date: January 20, 2025 Product Type: Food & Beverages Allergens Reason for Announcement: Recall Reason Description Undeclared milk. Company Name: Wismettac Asian Foods, Inc. Brand Name: Brand Name(s) Product Description: Product Description Snack foods-Corn Puffs Company Announcement Wismettac Asian Foods, Inc., Santa Fe Springs, CA is…
Monkey Spit, LLC Issues Allergy Alert on Undeclared Milk/Wheat/Soy in Monkey Spit BBQ Sauces
Summary Company Announcement Date: January 17, 2025 FDA Publish Date: January 17, 2025 Product Type: Food & Beverages Gravy/Sauces Allergens Reason for Announcement: Recall Reason Description Undeclared Milk, Soy, and Wheat Company Name: Monkey Spit, LLC. Brand Name: Brand Name(s) Monkey Spit Product Description: Product Description Barbecue sauces Company Announcement Monkey Spit, LLC, Nipomo, CA,…
Max Mobility / Permobil Issues Nationwide Recall of SmartDrive Speed Control Dial Due to the Motor Being Unresponsive to the User
Summary Company Announcement Date: January 14, 2025 FDA Publish Date: January 17, 2025 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Due to potential safety and performance concerns. Company Name: Max Mobility, LLC. Brand Name: Brand Name(s) Max Mobility/Permobil Product Description: Product Description Speed Control Dial Component Company Announcement Reason for Voluntary Field…
FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory acute graft versus host disease in pediatric patients
Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we’ll provide a quick update on a recent FDA cancer therapeutic approval. On December 18, 2024, the FDA approved remestemcel-L-rknd (brand name…
Early Alert: Infusion Pump Software Issue from Fresenius Kabi USA
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected Product The FDA is aware that Fresenius Kabi USA has…